TY  - JOUR
AU  - Lizak, Nathaniel
AU  - Malpas, Charles B
AU  - Sharmin, Sifat
AU  - Havrdova, Eva Kubala
AU  - Horakova, Dana
AU  - Izquierdo, Guillermo
AU  - Eichau, Sara
AU  - Lugaresi, Alessandra
AU  - Duquette, Pierre
AU  - Girard, Marc
AU  - Prat, Alexandre
AU  - Larochelle, Catherine
AU  - Trojano, Maria
AU  - Grand'Maison, Francois
AU  - Grammond, Pierre
AU  - Sola, Patrizia
AU  - Ferraro, Diana
AU  - Hupperts, Raymond
AU  - Bergamaschi, Roberto
AU  - Boz, Cavit
AU  - Van Pesch, Vincent
AU  - Spitaleri, Daniele
AU  - Terzi, Murat
AU  - Kalincik, Tomas
AU  - MSBase Study Group
PY  - 2020
DO  - 10.1001/jamaneurol.2020.2453
UR  - http://hdl.handle.net/10668/16003
T2  - JAMA neurology
AB  - It is unclear whether relapses and disease-modifying therapies are associated with the rate of disability accumulation in patients with secondary progressive multiple sclerosis (SPMS). To examine the association of relapses with the rate of disability...
LA  - en
KW  - Adult
KW  - Cohort Studies
KW  - Disabled Persons
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunotherapy
KW  - Longitudinal Studies
KW  - Male
KW  - Multiple Sclerosis, Chronic Progressive
KW  - Prospective Studies
KW  - Treatment Outcome
KW  - Young Adult
TI  - Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.
TY  - research article
VL  - 77
ER  -